Recombinant G-CSF for abortion, habitual

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Jul 2026: Trial started, NCT07724405
  2. 24 Jul 2026: Trial registered, NCT07724405

The trials

NCT07724405: Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage

State
Under way
Phase
Phase 2
People
150 planned
Started
10 Jul 2026
Primary completion
10 Aug 2027
Arms
Recombinant G-CSF 130 mcg SC
Results
None posted
  1. 10 Jul 2026: Trial started
  2. 24 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.